Home / Inspections / 1162640

FDA Inspection 1162640 — Altaire Pharmaceuticals, Inc.

Altaire Pharmaceuticals, Inc. — FEI 1000119582

The FDA completed an inspection of Altaire Pharmaceuticals, Inc. on February 11, 2022 in Aquebogue, NY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
February 11, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Aquebogue, NY (United States)

Facility

Other inspections at this facility

  • 1314330 (OAI Tue Apr 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1251507 (NAI Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1089315 (OAI Fri Apr 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1005208 (VAI Thu Mar 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 955795 (VAI Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources